Jr. Slemmon et al., INCREASED LEVELS OF HEMOGLOBIN-DERIVED AND OTHER PEPTIDES IN ALZHEIMERS-DISEASE CEREBELLUM, The Journal of neuroscience, 14(4), 1994, pp. 2225-2235
Several studies point to the importance of peptides and proteolysis in
Alzheimer's disease (AD). Because of its ability to study small prote
ins and peptides, reverse-phase HPLC was employed to study these speci
es in AD. Cerebellum was chosen for these initial studies because it d
oes not show significant neuronal loss but does show some pathology in
AD. Examination of over 600 peptide peaks per case revealed 15 that w
ere elevated in AD. Nine were fragments of hemoglobin, and the remaind
er included two species of calmodulin, two of myelin basic protein, an
d one each of 67 kDa neurofilament protein and PEP-19. The cleavage si
tes on hemoglobin were after hydrophobic residues and immunolocalizati
on was seen preferentially around blood vessel walls and granule cells
. The elevation of the non-serum-derived peptides was characteristic o
f general metabolic changes that occurred in AD cerebellum, and the pr
esence of elevated hemoglobin polypeptides indicated either possible d
isruption of the blood-brain barrier or selective evasion of it by pep
tidaceous products. Further studies are required to establish whether
hemoglobin fragments have a role in neurodegenerative processes such a
s AD.